HOME >> MEDICINE >> NEWS
Uncontrolled high blood pressure means more cognitive problems in old age

WASHINGTON -- People with high blood pressure and their doctors have a new reason to work at controlling this common but high-risk condition: As patients get older, they might otherwise have worse-than-normal problems with short-term memory and verbal ability. New research shows that uncontrolled hypertension puts people at higher risk for sharper drops in these cognitive functions than does blood pressure that's normal due to diet, exercise and/or medication. The study appears in the current issue of Neuropsychology, which is published by the American Psychological Association (APA).

Because blood pressure typically increases with age, hypertension affects 60 percent of adults age 60 and older. However, this "silent killer" often goes undetected or inadequately treated, leaving nearly 40 percent of older hypertensive people with continued high readings -- even with treatment. As a result, the findings suggest that a substantial number of older people with uncontrolled hypertension will experience significant cognitive declines, especially because with age, hypertension becomes more common and harder to control.

Researchers at the Veterans Affairs (VA) Boston Healthcare System, Harvard Medical School and the Boston University School of Public Health looked at a subset of men in the VA Normative Aging Study, a longitudinal study that started in 1963 and added neuropsychological tests in 1993. In this smaller cross-sectional study, 357 men from the larger sample averaged 67 years of age, lived in the community, didn't have dementia or other serious medical problems, and showed stable blood pressure over a three-year interval. Hypertension was defined as measuring 140/90 and higher.

Co-authors Christopher Brady, PhD, Avron Spiro III, PhD, and J. Michael Gaziano, MD, MPH, found that the older the men, the predictably lower their overall neuropsychological performance. However, older men in the sample with uncontrolled hypertension did s
'"/>

Contact: Pam Willenz
pwillenz@apa.org
American Psychological Association
4-Dec-2005


Page: 1 2

Related medicine news :

1. Uncontrolled use of artemisinin leading to drug-resistant malaria
2. Even low levels of weekly exercise drive down blood pressure
3. Chemotherapy with bevacizumab increases risk of blood clots in arteries
4. High blood pressure problems largely misunderstood by sufferers
5. Trial stops after stroke and mortality significantly reduced by blood
6. Program announced to improve care in developing areas for patients with blood disorders
7. New nutritional research: College students face obesity, high blood pressure, metabolic syndrome
8. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
9. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
10. Mercurys link to heart disease begins in blood vessel walls
11. Soy nuts may improve blood pressure in postmenopausal women

Post Your Comments:
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians and ... and musculoskeletal diseases gathered here for the World ... time in the 17-year history of the field’s ... is an emerging non-pharmaceutical protocol for enhancing bone ... Wolff’s law, osteogenic loading at multiples of body ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Cached News: